Back to School for Biotech
How Academia and Industry Can Collaborate to Advance Biologic Drug Development and Manufacturing
The Shifting Field of Stem Cell Regulations
Recent FDA Hearings Addressed Concerns Around Clinics Offering Cellular Therapies to Consumers
Enhancing Graduate and Postdoc Education for a Sustainable Workforce
Ph.D.-Trained Biomedical Scientists Can No Longer Count on Finding Academic Positions Upon Graduation
Unlucky 13: Top Clinical Trial Failures of 2016
In Missing Primary Endpoints, These Drugs Touched Off Stock Selloff, Layoffs, and Worse
Meet The GEN Team
John Sterling, Editor in Chief —
John joined Genetic Engineering & Biotechnology News as an assistant editor in 1984 and became editor-in-chief in 1989. He holds a B.S. in biology from CCNY and a Master of Arts in journalism from the University of Minnesota. John also was a graduate student at Hunter College where he majored in biological anthropology, focusing on the morphological and genetic aspects of human evolution.
He is an active member of the National Association of Science Writers, the Society of Professional Journalists, and the American Association of Anthropological Genetics and has received journalism fellowships from the University of Minnesota, the University of Maryland, and the Virginia Bioinformatics Institute at Virginia Tech University. He is a frequent guest speaker and moderator of biotechnology panel discussions at conferences in the U.S., Europe, and Asia. In 2009, John was selected to serve as co-chair of the program committee for the Biotechnology Industry Organization's annual conference in Chicago in May 2010.
John is a former intercollegiate ice hockey player at CCNY and still lives and dies with the New York Rangers.
Tamlyn Oliver, Managing Editor —
Tamlyn has been an editor at GEN since 1998. She has a degree in biology from the University of Massachusetts at Amherst and was previously managing editor of the Journal of Soil Contamination and publication coordinator at Amherst Scientific Publishers.
Tamlyn, a former competitive runner and triathlete, is now hooked on golf.
Jeffrey S. Buguliskis, Ph.D., Technical Editor —
Jeff joined GEN in 2015. He has a Ph.D. in Molecular Cell Biology from Thomas Jefferson University, where until recently he was a research faculty member. He has a broad background in the life sciences with particular expertise in molecular parasitology.
Jeff is a devoted Philadelphia sports fan and a self-described foodie.
Robert M. Reis, Production Editor —
Rob has been involved with trade publishing for more than 30 years. Having previously worked in the Mary Ann Liebert, Inc. medical journal production department and as production editor for the company's Natural Pharmacy magazine, he has been with GEN since mid-2001.
In addition to his New York University journalism degree, with a specialty in magazine production and editing, Rob is also a published writer and photographer.
In his spare time he enjoys hiking and rock climbing, both outdoors and at indoor rock climbing gyms, and is a long-time country music listener.
James Lambo, Art Director —
James has worked with the GEN team since 1997. He joined the staff as art director in 2006. Before joining GEN he was an art director for a calendar company on the west coast. He enjoys the ever advancing challenges of magazine publishing and has embraced new skills including digital video production.
He comes from an artistic family—both his sisters, and both parents are professional watercolorists—but James prefers working in oils when he can find the time. James has a BA in graphic design from Pratt Institute.
Kevin Mayer, Senior Editor —
Kevin joined GEN in 2013 after a brief stint at ScienceNY.com, a blog about popular science events in New York City. Previously, Kevin covered technology-based economic development, contributing columns to Trade & Industry Development, which focuses on state-led industry-clustering efforts, and serving in various editorial capacities at Technology Marketing Corporation (TMC), which promotes the democratization of telephony development via PC technology.
Kevin also has extensive experience in educational publishing. For example, at Grolier/Scholastic, he contributed updates to a range on print and online science references while augmenting the physical science coverage of an online textbook. Whether adding chapters, timelines, or special features, Kevin strove to create content that was not only comprehensive and informative but also engaging.
After graduating from Union College with a B.S. in chemistry, Kevin did some environmental work but soon gravitated toward publishing. Like many who began pursuing academic science publishing, his first job was at Plenum (before it was acquired by Kluwer). He also worked at the New York Academy of Sciences, mostly on biomedical proceedings.
Alex Philippidis, Senior News Editor —
Alex Philippidis specializes in biopharma business news and industry issues for GEN. Alex joined GEN in 2011 after four years at GenomeWeb L.L.C., where he covered research institutes and spent three years following biotech economic development as editor of the weekly newsletter BioRegion News. Previously, Alex worked more than 20 years for various newspapers covering business, science, Navy, and general-interest news. He has been interviewed and quoted by news outlets that include The New York Times and the BBC.
Alex enjoys solving crossword puzzles, watching classic TV game shows, and traveling with his family.
Katherine Vuksanaj, Online Coordinator —
Katherine joined GEN in July 2014. She’s been involved in the publishing industry for nineteen years. Before becoming a member of the GEN staff, she spent eight years at BusinessWeek magazine as an online production manager.
Katherine enjoys the beach, movies, and family time.
Melinda Kucsera, Web Producer —
Melinda has extensive experience in all aspects of online production and project management. Since 2002, she supported websites for nonprofits such as ArtsWestchester and e-commerce sites for catalog retailers such as Lillian Vernon Corp. and Spiegel Brands Inc. Melinda holds a B.A. in English and communications and an M.S. in publishing, both from Pace University.
She enjoys working out, singing in a local church choir, and dabbling in photography.
Thomas Mathew, Online Product Manager —
Thomas has nearly 20 years of magazine publishing experience from new business acquisition to database marketing to retention. Prior to joining GEN, he worked with several major publishers including Bonnier, Crain's New York Business, and Nature Publishing Group. He has a Bachelor's degree from Baruch College.
Thomas enjoys sports, fine dining, running, and building personal computers.
Angelo DePalma, Ph.D.
Angelo DePalma has been a freelance contributor to GEN for over 21 years. His editorial expertise ranges from biomanufacturing to basic science, instrumentation, and healthcare policy. Angelo's nearly 2,000 articles have appeared in more than 30 journals, trade publications, and websites. Angelo holds a Ph.D. in organic chemistry from Stony Brook University.
His interests include chess, gardening, and tennis.
Gail Dutton is fascinated with the intersection of science and business. Her interest in microbial bioremediation led her to GEN as a freelance writer in 1990. Her expertise extends into the fields of global trade and enterprise computing, which inform many of her GEN articles. Gail has a B.S. in journalism.
Gail enjoys photography, hiking and reading, and plays classical piano. She and her family traded life in Los Angeles for life on a tree farm in Washington State.
Patricia F. Dimond, Ph.D.
Patricia Dimond has been a long-time contributor to Genetic Engineering and Biotechnology News. Currently, she is president of BioInsight Communications, a strategic communications consultancy for the biotechnology industry. During her career in the biotechnology industry, she was vp of strategic development and corporate communications at Coley Pharmaceutical Group (now Pfizer), where she developed and managed the company's investor relations and communications programs and raised $28 million in the company's final pre-IPO private equity financing. Prior to joining Coley, Dr. Dimond held positions at Noonan/Russo Communications, Genzyme Transgenics Corporation, and at PerSeptive Biosystems. Dr. Dimond has written over 400 articles about the business and science of biotechnology. She holds an M.S. in scientific communication from Boston University, an M.Sc. in membrane biophysics from Georgetown University School of Medicine, and a Ph.D. in cellular biochemistry and molecular biology from The Catholic University of America.
She spends her nonexistent free time enjoying cooking, traveling, and reading cheesy novels, especially political thrillers.
Vicki Glaser has been a freelance contributor to GEN since 1991. She has Bachelor's degrees in biology and psychology from the University of Virginia and a Master's degree in genetics from the University of Pennsylvania. Vicki began her career in science and medical writing on the staff of Nature Biotechnology and then was managing editor of the New York State Journal of Medicine. She has been a freelance writer for the past 24 years.
Vicki enjoys reading, running, and taking long walks with her dog.